---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-21-060020"
form_type: "8-K"
ticker: "KZR"
cik: "0001645666"
company_name: "Kezar Life Sciences, Inc."
filed_at: "2021-12-10T23:59:59+00:00"
generated_at: "2026-06-28T02:04:50.707384+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Kezar Life Sciences appoints Courtney Wallace to board; director Jason Dinges resigns

## Summary
- Jason Dinges, Ph.D., resigned from the board effective Dec 9, 2021; departure not due to disagreement.
- Courtney Wallace appointed as Class I director, serving until 2022 annual meeting or successor.
- Wallace receives annual cash compensation of $35,000 plus initial option for 52,000 shares vesting monthly over 3 years.

## SEC filing metadata
- accession: 0001564590-21-060020
- form_type: 8-K
- ticker: KZR
- cik: 0001645666
- company_name: Kezar Life Sciences, Inc.
- filed_at: 2021-12-10T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/0001564590-21-060020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/kzr-8k_20211209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-21-060020
- JSON: https://secwatch.observer/filing/0001564590-21-060020.json
- Plain text: https://secwatch.observer/filing/0001564590-21-060020.txt

## Key facts
- Executive change
  Jason Dinges resigned as Director at Kezar Life Sciences, Inc..
  - Action: resigned
  - Role: Director
  source text: Effective December 9, 2021, Jason Dinges, Ph.D., resigned from the Board of Directors (the “Board”) of Kezar Life Sciences, Inc. (the “Company”) and from his position as a member of the Nominating and Corporate Governance Committee of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/0001564590-21-060020-index.htm
- Executive change
  Courtney Wallace was appointed as Director at Kezar Life Sciences, Inc..
  - Action: appointed
  - Role: Director
  source text: Effective December 9, 2021, the Board appointed Courtney Wallace to the Board as a Class I Director, to serve until the Company’s 2022 annual meeting of stockholders and until her successor is duly elected and qualified, or her earlier resignation or removal.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/0001564590-21-060020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.